CSF protein ratios with enhanced potential to reflect Alzheimer’s disease pathology and neurodegeneration
2024 · Molecular Neurodegeneration · 22 citations
https://doi.org/10.1186/s13024-024-00705-z
V
Vilma Alanko
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
80
Citations
4
h-index
4
i10-index
Vilma Alanko is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Alzheimer's disease research and treatments & Dementia and Cognitive Impairment Research & Neuroinflammation and Neurodegeneration Mechanisms. The author has an h-index of 4, co-authored 17 publications.
ORCID: 0000-0001-9918-9429Papers by this author
worksCommonly prescribed multi‐medication therapies exert sex‐specific effects on Alzheimer's disease pathology and metabolomic profiles in <i>App<sup>NL‐G‐F</sup></i> mice: Implications for personalized therapeutics in aging
2025 · Alzheimer s & Dementia · 3 citations
https://doi.org/10.1002/alz.70081
Mechanisms of interventions targeting modifiable factors for dementia risk reduction
2025 · Molecular Neurodegeneration · 3 citations
https://doi.org/10.1186/s13024-025-00845-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat